Home / Recalls / Drug Depot, Inc., dba APS Pharmacy / D-0728-2022

D-0728-2022 Class II Terminated

Recalled by Drug Depot, Inc., dba APS Pharmacy — Palm Harbor, FL

Recall Details

Product Type
Drugs
Report Date
April 6, 2022
Initiation Date
March 23, 2022
Termination Date
October 5, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
6017 vials

Product Description

GONADORELIN (5ML) 0.2 MG/ML INJECTABLE, Packaged in a multi dose 10ML vial, Formula ID132227, APS Pharmacy

Reason for Recall

Lack of sterility assurance.

Distribution Pattern

Nationwide in the USA including Puerto Rico.

Code Information

Lots: 745708 BUD: 6/21/2022; 753364 BUD: 7/27/2022; 752508 BUD: 7/24/2022; 750313 BUD: 7/16/2022; 753020 BUD: 7/26/2022; 747712 BUD: 7/4/2022; 747974 BUD: 7/5/2022; 754802 BUD: 8/3/2022; 751158 BUD: 7/19/2022; 756837 BUD: 8/16/2022; 748939 BUD: 7/10/2022; 750842 BUD: 7/18/2022; 755742 BUD: 8/8/2022; 758691 BUD: 8/28/2022; 758432 BUD: 8/27/2022; 758975 BUD: 8/29/2022; 756643 BUD: 8/15/2022

Other recalls by Drug Depot, Inc., dba APS Pharmacy

  • D-0731-2022 Class II — TESTOSTERONE CYPIONATE/ ANASTROZOLE *GS* OIL (10ML) 200MG/0.5MG/ML; Packaged in (March 23, 2022)
  • D-0732-2022 Class II — TESTOSTERONE CYPIONATE/ DHEA *GS* 200/10MG/ML Injectable, Packaged in a multi do (March 23, 2022)
  • D-0733-2022 Class II — TESTOSTERONE CYPIONATE/PROPIONATE *SES* Oil (10 ML) 160MG/20MG/ML Injectable, Pa (March 23, 2022)
  • D-0730-2022 Class II — TESTOSTERONE CYPIONATE/ANASTROZOLE *GS* OIL 200MG/1MG/ML Injectable, Packaged i (March 23, 2022)
  • D-0734-2022 Class II — TESTOSTERONE CYPIONATE *GS* Oil 200 MG/ML Injectable, Packaged in a multi dose 1 (March 23, 2022)
  • D-0729-2022 Class II — (CA) GONADORELIN (4ML) 0.2 MG/ML INJECTABLE, Packaged in a multi dose 10ML vial, (March 23, 2022)
  • D-0735-2022 Class II — TESTOSTERONE CYPIONATE *GS* (2 mL) 80 MG/ML Injectable, Packaged in a multi dos (March 23, 2022)